Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial

BackgroundHigh‐potency statins reduce cardiovascular events after acute coronary syndromes but remain underused in clinical practice. We examined predictors of nonuse of high‐potency statins after acute coronary syndromes. Methods and ResultsThe Stabilization of pLaques usIng Darapladib‐Thrombolysis...

Full description

Bibliographic Details
Main Authors: Alon Eisen, Christopher P. Cannon, Eugene Braunwald, Dylan L. Steen, Jing Zhou, Erica L. Goodrich, KyungAh Im, Anthony J. Dalby, Jindrich Spinar, Shruti Daga, Mary Ann Lukas, Michelle L. O'Donoghue
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
guideline
secondary prevention
statin therapy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004332

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.004332

Similar Items